tradingkey.logo
搜索

Mangoceuticals Inc

MGRX
添加自选
0.380USD
+0.015+4.11%
收盘 06/30, 16:00美东报价延迟15分钟
6.52M总市值
亏损市盈率 TTM

Mangoceuticals Inc

0.380
+0.015+4.11%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+4.11%

5天

+9.51%

1月

-11.63%

6月

-48.65%

今年开始到现在

-48.65%

1年

-75.00%

关键数据
0.360今开
0.380最高
329.19K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
1.94%换手率
0.365昨收
0.345最低
93.38K成交额
亏损市盈率静
0.48市净率
0.00%股息率 TTM
-106.11%ROA
2.87552周最高
0.13量比
-8.71M净利润
16.97M总股本
-1.3192每股收益TTM
--Beta
-120.87%ROE
0.16252周最低
9.56%振幅
-365.16%毛利率
6.52M总市值
-1.35回报/风险
9.70%风险率

TradingKey Mangoceuticals Inc股票评分

单位: USD 更新时间: 2026-06-30

操作建议

Mangoceuticals Inc当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗服务供应商行业排名65/76位。机构持股占比非常高,中期看,股价处于上升通道。近一个月,市场表现一般,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Mangoceuticals Inc评分

相关信息

行业排名
65 / 76
全市场排名
520 / 4569
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Mangoceuticals Inc亮点

亮点风险
Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
业绩增长期
公司处于发展阶段,最新年度总收入456.02K美元
利润高增长
公司净利润处于行业前列,最新年度总收入456.02K美元
估值高估
公司最新PE估值-0.29,处于3年历史高位
机构加仓
最新机构持股2.67M股,环比增加44.53%

分析师目标

根据 0 位分析师
--
评级
--
目标均价
--
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Mangoceuticals Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Mangoceuticals Inc简介

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
公司代码MGRX
公司Mangoceuticals Inc
CEOCohen (Jacob D)
网址https://www.mangorx.com/

常见问题

Mangoceuticals Inc(MGRX)的当前股价是多少?

Mangoceuticals Inc(MGRX)的当前股价是 0.38。

Mangoceuticals Inc的股票代码是什么?

Mangoceuticals Inc的股票代码是MGRX。

Mangoceuticals Inc股票的52周最高点是多少?

Mangoceuticals Inc股票的52周最高点是2.88。

Mangoceuticals Inc股票的52周最低点是多少?

Mangoceuticals Inc股票的52周最低点是0.16。

Mangoceuticals Inc的市值是多少?

Mangoceuticals Inc的市值是6.45M。

Mangoceuticals Inc(MGRX)股票的每股收益(EPS TTM)是多少

Mangoceuticals Inc(MGRX)股票的每股收益(EPS TTM)是-2.17。
KeyAI